In addition, we found that the E2F1 was recruited to the FOXM1 promoter region, indicating that CDCA5 was capable to affect FOXM1 expression via binding to E2F1, thereby promoting in the progression of breast cancer. The gene discussed is CDCA5; the disease is breast cancer.